Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization

British Journal of Haematology

Volumn 98, Issue 4, 1997, Pages 913-921

  Clodi, Katharina ^a   Younes, Anas ^a   Goodacre, Angela ^a   Roberts, Mark ^a   Palmer, Judy ^a   Younes, Mamoun ^b   Cabanillas, Fernando ^a   Andreeff, Michael ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Fluorescence in situ hybridization (FISH); Non Hodgkin's lymphomas; P53

Indexed keywords

ARTICLE; CANCER SURVIVAL; CHROMOSOME 17P; CLINICAL ARTICLE; FEMALE; FLUORESCENCE; GENE DELETION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0030768049     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3143131.x     Document Type: Article

References (39)

1. Adamson, D.J., Thompson, W.D., Dawson, A.A., Bennett, B. & Haites, N.E. (1995) p53 mutation and expression in lymphoma. British Journal of Cancer, 72, 150-154.
2. Andreeff, M., Hansen, H., Cirrincione, C., Filippa, D. & Thaler, H. (1986) Prognostic value of DNA/RNA flow cytometry of B-cell non-Hodgkin's lymphoma: development of laboratory model and correlation with four taxonomic systems. Annals of the New York Academy of Science, 468, 368-386.
3. Ashmun, R.A., Look, A.T., Roberts, W.M., Roussel, M.F., Seremetis, S., Shtsuka, M. & Sherr, C.J. (1989) Monoclonal antibodies to the human CSF-1 receptor (c-fms proto-oncogene product) detect epitopes on normal mononuclear phagocytes and on human myeloid leukemic blast cells. Blood, 73, 827-837.
4. Bergh, J., Norberg, T., Sjogren, S., Lindgren, A. & Holmberg, L. (1995) Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nature Medicine, 1, 1029-1034.
5. Biegel, J.A., Burk, C.D., Barr, T.G. & Emanuel, B.S. (1992) Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Research 52, 3391-3395.
6. Cabanillas, F., Pathak, S., Grant, G., Hagemeister, F.B., McLaughlin, P., Swan, F., Rodriguez, M.A., Trujillo, J., Cork, A., Butler, J.J., Katz, R., Bourne, S. & Freireich, E.J. (1989) Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. American Journal of Medicine, 87, 167-172.
7. Chang, F., Syrjanen, S. & Syrjanen, K. (1995) Implications of the p53 tumor-suppressor gene in clinical oncology. Journal of Clinical Oncology, 13, 1009-1022.
8. Coles, C., Thompson, A.M., Elder, P.A., Cohen, B.B., Mackenzie, I.M., Granston, G., Chetty, U., Mackay, J., MacDonald, M., Nakamura, Y., Hoyheim, B. & Steel, C.M. (1990) Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336, 761-763.
9. Doehner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hustein, W. & Lichter, P. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580-1589.
10. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. & Dalla-Favera, R. (1991) p53 mutations in human malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 88, 5413-5417.
11. Harris, N.L., Jaffe, E., Stein, H., Banks, P.M., Chan, J.K., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S., Piris, M.A., Ralfkiaer, E. & Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84, 1361-1391.
12. Ichikawa, A., Hotta, T., Takagi, N., Tsushita, K., Kinoshita, T., Nagai, H., Murakami, Y., Hayashi, K. & Saito, H. (1992) Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood, 79, 2701-2707.
13. Imamura, J., Miyoshi, I. & Koeffler, H.P. (1994) p53 in hematologic malignancies. Blood, 84, 2412-2421.
14. Jendiroba, D., Younes, A., Katz, R., Cabanillas, F. & Andreeff, M. (1995) Chromosome 17 numerical abnormalities in 55 patients with non-Hodgkin's lymphoma: a fluorescence in situ hybridization study. Leukemia, 9, 1144-1146.
15. Kramer, M.H.H., Hermans, J., Parker, J., Krol, A.D.G., Kluin-Nelemans, J.C., Haak, H., Groninigen, K., van Krieken, H.J.M., van de Jong, D. & Kluin, Ph.M. (1996) Clinical significance of bcl-2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. Journal of Clinical Oncology, 14, 2131-1238.
16. Lamb, P. & Crawford, L. (1986) Characterization of the human p53 gene. Molecular and Cellular Biology, 6, 1379-1385.
17. Lengauer, C., Riethman, H.C., Speicher, M.R., Taniwaki, M., Konecki, D., Green, E.D., Becher, R., Olson, M.V. & Cremer, T. (1992) Metaphase and interphase cytogenetics with Alu-PCR-amplified yeast artificial chromosome clones containing the BCR gene and the protooncogenes c-raf-1, c-fms, and c-erbB-2. Cancer Research, 52, 2590-2596.
18. Levine, A.J., Momand, J. & Finlay, C.A. (1991) The p53 tumour suppressor gene. Nature, 351, 453-456.
19. Levine, E.G., Arthur, D.C., Frizzera, G., Peterson, B.A., Hurd, D.D. & Bloomfield, C.D. (1988) Cytogenetic abnormalities predict clinical outcome in non-Hodgkin's lymphoma. Annals of Internal Medicine 108, 14-20.
20. Lichter, P., Tang, C.J., Call, K., Hermanson, G., Evans, G.A., Housman, D. & Ward, D.C. (1990) High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science, 247, 64-69.
21. Lo Coco, F., Gaidano, G., Louie, D.C., Offit, K., Chaganti, R.S. & Dalla-Favera, R. (1993) p53 mutations are associated with histologic transformation of follicular lymphoma. Blood, 82, 2289-2295.
22. Matsuhama, H., Pan, Y., Mahdy, E.A., Malmstroem, P.U., Hedrum, A., Uhlen, M., Busch, C., Hirano, T., Auer, G., Tribukait, B., Naito, K., Lichter, P., Ekman, P. & Bergerheim, U.S.R. (1994) p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Research, 54, 6057-6060.
23. Matsushima, A.Y., Cesarman, E., Chadburn, A. & Knowles, D.M. (1994) Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. American Journal of Pathology, 144, 573-584.
24. Piris, M.A., Villuendas, R., Martinez, J.C., Sanchez-Beato, M., Orradre, J.L., Mateo, M.S. & Martinez, P. (1995) p53 expression in non-Hodgkin's lymphomas: a marker of p53 inactivation? Leukemia and Lymphoma, 17, 35-42.
25. Preudhomme, C., Dervite, I., Wattel, E., Vanrumbeke, M., Flactif, M., Lai, J.L., Hecquet, B., Coppin, M.C., Nelken, B., Gosselin, B. & Fenaux, P. (1995) Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases. Journal of Clinical Oncology, 13, 812-820.
26. Prokocimer, M. & Rotter, V. (1994) Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood, 84, 2391-2411.
27. Rodriguez, M.A., Ford, R.J., Goodacre, A., Selvanayagam, P., Cabanillas, F. & Deisseroth, A.B. (1991) Chromosome 17- and p53 changes in lymphoma. British Journal of Haematology, 79, 575-582.
28. Rosen, P.P., Lesser, M.L., Arroyo, C.D., Cranor, M., Borgen, P. & Norton, L. (1995) p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. Journal of Clinical Oncology, 13, 821-830.
29. Said, J.W., Barrera, R., Shintaku, I.P., Nakamura, H. & Koeffler, H.P. (1992) Immunohistochemical analysis of p53 expression in malignant lymphomas. American Journal of Pathology, 141, 1343-1348.
30. Sander, C.A., Yano, T., Clark, H.M., Harris, C., Longo, D.L., Jaffe, E.S. & Raffeld, M. (1993) p53 mutation is associated with progression in follicular lymphomas. Blood, 82, 1994-2004.
31. Soussi, T., Legros, Y., Lubin, R., Ory, K. & Schlichtholz, B. (1994) Multifactorial analysis of p53 alteration in human cancer: a review. International Journal of Cancer, 57, 1-9.
32. Tilly, H., Rossi, A., Stamatoullas, A., Lenormand, B., Bigorgne, C., Kunlin, A., Monconduit, M. & Bastard, C. (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood, 84, 1043-1049.
33. Verbeek, J.S., Roebroek, A.J.M., van den Ouweland, A.M.W., Bloemers, H.P.J. & van de Ven, W.J.M. (1985) Human c-fms proto-oncogene: comparative analysis with an abnormal allele. Molecular and Cellular Biology, 5, 422-428.
34. Villuendas, R., Piris, M.A., Algara, P., Sanchez-Beato, M., Sanchez-Verde, L., Martinez, J.C., Orradre, J.L., Garcia, P., Lopez, C. & Martinez, P. (1993) The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood, 82, 3151-3156.
35. Villuendas, R., Piris, M.A., Orradre, J.L., Mollejo, M., Algara, P., Sanchez, L., Martinez, J.C. & Martinez, P. (1992) p53 protein expression in lymphomas and reactive lymphoid tissue. Journal of Pathology, 166, 235-241.
36. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P. & Fenaux, P. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148-3157.
37. Younes, A., Jendiroba, D., Engel, H., Escudier, S., Katz, R., Rodriguez, M.A., Hill, D., Cabanillas, F. & Andreeff, M. (1994a) High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement. Cancer Genetics and Cytogenetics, 77, 39-44.
38. Younes, A., Pugh, W., Goodacre, A., Katz, R., Rodriguez, M.A., Hill, D., Cabanillas, F. & Andreeff, M. (1994b) Polysomy of chromosome 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: differences between follicular and diffuse large cell lymphoma. Genes, Chromosomes and Cancer, 9, 161-167.
39. Wolf, D., Laver-Rudich, Z. & Rotter, V. (1985) In vitro expression of human p53 cDNA clones and characterization of the cloned human p53 gene. Molecular and Cellular Biology, 5, 1887-1893.